Want to see SHC full AI Analyst Report?
SHC Stock Chart & Stats
$17.40
-$0.21(-1.56%)
At close: 4:00 PM EST
$17.40
-$0.21(-1.56%)
Day’s Range― - ―
52-Week Range$10.98 - $19.85
Previous CloseN/A
Volume149.43K
Average Volume (3M)2.63M
Market Cap
$5.06B
Enterprise Value$6.08K
Total Cash (Recent Filing)$315.94M
Total Debt (Recent Filing)$2.27B
Price to Earnings (P/E)43.2
Beta1.16
Next Earnings
Aug 06, 2026EPS Estimate
0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.41
Shares Outstanding285,167,000
10 Day Avg. Volume2,550,209
30 Day Avg. Volume2,634,788
Financial Highlights & Ratios
PEG Ratio0.95
Price to Book (P/B)8.27
Price to Sales (P/S)4.30
P/FCF Ratio33.58
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$21.67Price Target Upside24.52% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.97
Revenue Forecast (FY)$1.24B
Bulls Say, Bears Say
Bulls Say
Regulated, Recurring Service ModelSotera’s core businesses provide mission‑critical sterilization and testing that customers routinely outsource to meet regulatory and quality requirements. This creates recurring revenue, high customer stickiness, and predictable baseline demand that supports revenue durability across cycles.
High‑margin Nordion PerformanceNordion’s specialized irradiation products deliver outsized margins and volume/mix gains, reflecting high barriers to entry and long product lifecycles. Strong contribution from this segment materially improves consolidated margin resilience and cash generation potential over the medium term.
Refinanced Term Loans To Ease Financing CostThe term‑loan repricing modestly lowers interest expense and extends maturities, reducing near‑term refinancing risk. That improved financing flexibility supports planned capex, deleveraging and operational investments without immediate pressure from short maturities.
Bears Say
Elevated LeverageSotera’s capital structure remains highly leveraged, increasing sensitivity to interest rates, refinancing windows and operational shocks. High leverage constrains strategic optionality, lengthens time needed to hit target leverage and amplifies downside risk if cash flow softens.
Weak Free Cash Flow ConversionAlthough operating cash flow can be solid, inconsistent free cash flow conversion limits the company’s ability to consistently pay down debt or fund growth. Volatility in FCF raises execution risk for deleveraging plans and heightens dependence on external financing for capex.
Regulatory Uncertainty Around EOPotential federal changes to ethylene oxide regulation could force additional compliance spending, disrupt Sterigenics throughput, or shift customer behavior. This regulatory risk is structural and could raise long‑term capex and operating costs, pressuring margins and utilization.
Sotera Health News
SHC FAQ
What was Sotera Health Company’s price range in the past 12 months?
Sotera Health Company lowest stock price was $10.98 and its highest was $19.85 in the past 12 months.
What is Sotera Health Company’s market cap?
Sotera Health Company’s market cap is $5.06B.
When is Sotera Health Company’s upcoming earnings report date?
Sotera Health Company’s upcoming earnings report date is Aug 06, 2026 which is in 18 days.
How were Sotera Health Company’s earnings last quarter?
Sotera Health Company released its earnings results on May 05, 2026. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.174 by $0.006.
Is Sotera Health Company overvalued?
According to Wall Street analysts Sotera Health Company’s price is currently Undervalued.
Does Sotera Health Company pay dividends?
Sotera Health Company does not currently pay dividends.
What is Sotera Health Company’s EPS estimate?
Sotera Health Company’s EPS estimate is 0.24.
How many shares outstanding does Sotera Health Company have?
Sotera Health Company has 285,167,000 shares outstanding.
What happened to Sotera Health Company’s price movement after its last earnings report?
Sotera Health Company reported an EPS of $0.18 in its last earnings report, beating expectations of $0.174. Following the earnings report the stock price went down -0.39%.
Which hedge fund is a major shareholder of Sotera Health Company?
Currently, no hedge funds are holding shares in SHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sotera Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$21.67 (24.52% Upside)
$21.67 (24.52% Upside)
Blogger Sentiment
Bullish
SHC Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 521.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $482.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 0.6%
Last 30 Days ▲ 0.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
58.05%
12-Months-Change
Fundamentals
Return on Equity
20.57%
Trailing 12-Months
Asset Growth
4.47%
Trailing 12-Months
Company Description
Sotera Health Company
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
SHC Stock 12 Month Forecast
Average Price Target
$21.67
▲(24.52% Upside)
Technical Analysis
Ownership Overview
2.75% Insiders
16.11% Mutual Funds
0.05% Other Institutional Investors
62.16% Public Companies and
Individual Investors